Some antibodies can dampen antiviral defences in people with severe COVID
- 16 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature
- Vol. 591 (7848), 37-39
- https://doi.org/10.1038/d41586-021-00352-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Global absence and targeting of protective immune states in severe COVID-19Nature, 2021
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityCell, 2020
- Relaxed peripheral tolerance drives broad de novo autoreactivity in severe COVID-19Published by Cold Spring Harbor Laboratory ,2020
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19Science, 2020
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansScience, 2020
- An immune-cell signature of bacterial sepsisNature Medicine, 2020
- Beyond binding: antibody effector functions in infectious diseasesNature Reviews Immunology, 2017
- Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response programThe Journal of Experimental Medicine, 2007